Loading company…
Single Pass develops a biopsy cauterization device designed to help control bleeding during procedures.
Founded in 2021 and based in Lake Forest, US, Single Pass develops a cauterization device for biopsy procedures. Its Single Pass probe operates at a maximum temperature of 90°C and is designed to help healthcare professionals control bleeding. In July 2021, the company raised Seed funding led by Tech Coast Angels and KYTO Technology & Life Science.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in